Price
$12.32+25.46%Social Signal Score
Analyst Ratings
12 analysts52-week range
- Last close
- $12.32
- Off 52w high
- 0.0%
- 200-day average
- $8.10
- vs 200-day
- +52.2%
Revenue
$670.48M+88.75%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Jeffrey S. Shaner
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 35,500
- Beta
- 1.97
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 1.91
Financials
Revenue
$670.48M+88.7%Net Income
$40.29M+7.1%EBITDA
$87.10M+29.7%Free Cash Flow
$79.64M+111.1%EPS (diluted)
$0.18-14.3%Shares Outstanding (diluted)
224.86M+24.8%Operating Expenses
$0.00Cash & Debt
$97.20MReturn of Capital
$0.00Revenue by Segment (annual)
$2.43BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.43B | $225.03M | $1.10 |
| 2024 | $2.02B | $-10.93M | $-0.06 |
| 2023 | $1.90B | $-134.52M | $-0.71 |
| 2022 | $1.79B | $-662.03M | $-3.57 |
| 2021 | $1.68B | $-117.04M | $-0.63 |
| 2020 | $1.50B | $-57.05M | $-0.31 |
| 2019 | $1.38B | $-76.52M | $-0.41 |
| 2018 | $1.25B | $-47.15M | $-0.26 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $1.62
- Implied price
- $11.37
- Return from $12.41
- -1.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $5.65 — -54.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 3 | 5 | 7 | 9 | 11 |
|---|---|---|---|---|---|
| -2.0% | -24.7% | -16.6% | -10.8% | -6.2% | -2.4% |
| 3.0% | -20.9% | -12.4% | -6.3% | -1.4% | 2.6% |
| 8.0% | -17.0% | -8.1% | -1.7% | 3.3% | 7.6% |
| 13.0% | -13.2% | -3.9% | 2.8% | 8.1% | 12.5% |
| 18.0% | -9.4% | 0.4% | 7.4% | 12.9% | 17.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70+40.00%Social Signal Score
Mentions (20)
- Newszacks.com·18d ago·Positive
Here's Why Aveanna Healthcare (AVAH) is a Great Momentum Stock to Buy Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Aveanna Healthcare Holdings Inc. (AVAH) Presents at Deutsche Bank 2026 Healthcare Summit Transcript Aveanna Healthcare Holdings Inc. (AVAH) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
View source ↗ - Newszacks.com·21d ago·Positive
Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run? Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
View source ↗ - Newsseekingalpha.com·36d ago·Neutral
Aveanna Healthcare: Increasing Earnings And Delevering Focus Make It An Appealing Stock Aveanna Healthcare Holdings demonstrates strong revenue and earnings growth, with a focus on private duty services and strategic M&A. AVAH trades at a low LTM P/E of 11.8x, reflecting its high leverage but also offering compelling value versus peers. Management targets reducing leverage below 3x, prioritizing cash-funded acquisitions and disciplined expansion to mitigate balance sheet risks.
View source ↗ - Newszacks.com·38d ago·Neutral
4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.
View source ↗ - Newszacks.com·38d ago·Positive
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue? Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
View source ↗ - Newszacks.com·39d ago·Neutral
Aveanna Healthcare (AVAH) Is Up 6.82% in One Week: What You Should Know Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newsglobenewswire.com·40d ago·Positive
Aveanna to Participate in the Deutsche Bank 2026 Healthcare Summit ATLANTA, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Deutsche Bank 2026 Healthcare Summit in New York on September 16, 2026. Management will host a fireside chat at 1:00pm EST along with 1x1 investor meetings that same day.
View source ↗ - Newszacks.com·40d ago·Neutral
Earnings Estimates Rising for Aveanna (AVAH): Will It Gain? Aveanna Healthcare (AVAH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
View source ↗ - Newsglobenewswire.com·42d ago·Neutral
Aveanna to Participate in the 2026 Jefferies Healthcare Services and Technology Conference ATLANTA, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026. Management will present at 4:10pm CST and will also host 1x1 investor meetings that same day.
View source ↗ - Newsglobenewswire.com·46d ago·Negative
Aveanna Announces Pricing of Secondary Offering of Common Stock ATLANTA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, announced today the pricing of the previously announced secondary offering by certain selling stockholders (the “Selling Stockholders”), including affiliates of J.H. Whitney Equity Partners VII, LLC and certain current and …
View source ↗ - Newsglobenewswire.com·46d ago·Negative
Aveanna Announces Launch of Secondary Offering of Common Stock ATLANTA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, announced today that certain selling stockholders (the “Selling Stockholders”), including affiliates of J.H. Whitney Equity Partners VII, LLC and certain current and former directors and officers of the Company, have commenc…
View source ↗ - Newsseekingalpha.com·53d ago·Positive
Aveanna Healthcare Holdings Inc. (AVAH) Q2 2026 Earnings Call Transcript Aveanna Healthcare Holdings Inc. (AVAH) Q2 2026 Earnings Call Transcript
View source ↗ - Newsseekingalpha.com·53d ago·Positive
…Aveanna Healthcare Holdings delivered strong Q2 2026 results, beating earnings and revenue estimates and significantly raising full-year EBITDA and revenue guidance. AVAH's valuation remains attractive versus peers, with the lowest forward P/E multiples and leading EBITDA margin, despite a 60% stock price gain since March. Private Duty Services drive 83% of revenues, but gross margins declined across all segments; rapid revenue growth offset margin pressure, yet this trend warrants monitoring.
View source ↗ - Newsmarketbeat.com·53d ago·Positive
Aveanna Healthcare Q2 Earnings Call Highlights Aveanna Healthcare NASDAQ: AVAH reported higher second-quarter revenue and adjusted EBITDA, supported by growth across its three operating divisions, improved reimbursement rates, increased volumes and operational efficiencies. The company also raised its full-year outlook and updated its long-term organic growth targets for its Private Duty Services and Home Health and Hospice businesses.
View source ↗ - Newszacks.com·53d ago·Neutral
Aveanna (AVAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
View source ↗ - Newszacks.com·54d ago·Positive
Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago.
View source ↗ - Newsglobenewswire.com·54d ago·Negative
…uidance to greater than $365 million, updated from between $338 and $342 million ATLANTA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and six-month periods ended July 4, 2026. Jeff Shaner, Chief Executive Officer, commented, “Our second quarter results demonstrate the momentum across Aveanna…
View source ↗ - Newszacks.com·56d ago·Negative
Is the Options Market Predicting a Spike in Aveanna Healthcare Stock? Investors need to pay close attention to AVAH stock based on the movements in the options market lately.
View source ↗ - Newszacks.com·56d ago·Negative
Gear Up for Aveanna (AVAH) Q2 Earnings: Wall Street Estimates for Key Metrics Besides Wall Street's top-and-bottom-line estimates for Aveanna (AVAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
View source ↗
Earnings
Thu, Nov 5(in 4 weeks)
Consensus estimate $0.20 per share
Typical surprise +63.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$0.22 vs $0.17beat
- Thu, May 14$0.18 vs $0.13beat
- Thu, Mar 19$0.17 vs $0.15beat
- Thu, Nov 6$0.15 vs $0.08beat
- Thu, Aug 7$0.18 vs $0.04beat
- Thu, May 8$0.10 vs $0.03beat
Estimates and results for AVAH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by AVAH officers and directors.
- Bought
- —
- Sold
- $575.1m
0 trades
76 trades
- J.h. Whitney Equity Partners Vii, Llcsold
- Williams Robert M Jrsold
- Vigano Paul Rsold
- J.h. Whitney Equity Partners Vii, Llcsold
- J.h. Whitney Equity Partners Vii, Llcsold
- Williams Robert M Jrsold
- Williams Robert M Jrsold
- Vigano Paul Rsold
24 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in AVAH.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.